Clinical trial Recruiting at 1 site Interventional Ages 18 and up Men only

Discharge education video to reduce post-operative healthcare use after HoLEP

Official title: The Impact of Discharge Educational Discharge Videos on Post-Operative Care Utilization After Holmium Laser Enucleation of the Prostate (HoLEP) Procedures

Run by University of California, San Francisco · NCT06975033 · Data updated 2026-11-12

This will test whether showing an educational discharge video to adults undergoing HoLEP reduces post-operative healthcare visits and improves patient satisfaction.

More Patient Satisfaction trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexMen only
Enrollment114 (estimated)
SponsorUniversity of California, San Francisco
Academic / other
Locations3 sites (San Francisco, California and 2 other locations)
StatusRecruiting
StartedNovember 4, 2025
Main results expectedDecember 1, 2026
Study endsDecember 1, 2026
Registry record updatedApril 16, 2026
Trial IDNCT06975033 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older scheduled for HoLEP who speak English, can provide informed consent, and are willing to complete baseline and follow-up surveys are ideal candidates.

Probably not a fit

Patients who are non-English speakers, unable to consent or complete surveys, or who do not have a prostate are not eligible and would not be expected to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized interventional study will enroll adults scheduled for Holmium Laser Enucleation of the Prostate (HoLEP) at three U.S. academic centers. After the procedure, participants will be randomized to watch a scripted educational discharge video or to receive standard discharge care without the video. Investigators will monitor post-operative healthcare utilization such as phone calls, emergency visits, and readmissions and will collect baseline and follow-up surveys. Secondary outcomes include patient satisfaction with discharge education.

Why it matters

Potential benefit: If successful, the video could lower unnecessary post-discharge calls and visits, increase patient confidence in self-care, and reduce healthcare costs.

How similar studies have gone: Educational discharge materials and videos have reduced post-operative calls and readmissions in other surgical populations, but this approach has been less studied specifically after HoLEP.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adults aged 18+
2. Patients scheduled for a HoLEP procedure
3. Patients willing to complete both baseline and follow up surveys
4. Patients able to provide informed consent
5. Patients are English-speaking and understand English

Exclusion Criteria:

1. Patients under 18+
2. Patients unable to consent
3. Patients unable to complete surveys
4. Patients without a prostate.
5. Patients are non-English speakers

Where it's running

  • University of California, San Francisco
    San Francisco, California, United States
    Recruiting
  • University of Rochester Medical Center
    Rochester, New York, United States
    Not yet recruiting
  • Scott SUNY Upstate Medical University
    Syracuse, New York, United States
    Not yet recruiting

Study contacts

  • Principal investigator: David Bayne, MD, MPH — University of California, San Francisco
  • Study coordinator: David Bayne, MD, MPH
  • Email: david.bayne@ucsf.edu
  • Phone: 617-571-5870

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.